Literature DB >> 768802

Clonidine and the anti-parkinsonian response to L-DOPA or piribedil.

I Shoulson, T N Chase.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 768802     DOI： 10.1016/0028-3908(76)90093-9

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN： 0028-3908            Impact factor:   5.250


× No keyword cloud information.
  9 in total

1.  Influence of noradrenaline denervation on MPTP-induced deficits in mice.

Authors:  T Archer; A Fredriksson
Journal:  J Neural Transm (Vienna)       Date:  2005-12-16       Impact factor: 3.575

2.  Restoration and putative protection in Parkinsonism.

Authors:  T Archer; A Fredriksson
Journal:  Neurotox Res       Date:  2000       Impact factor: 3.911

3.  On the mode of action of clonidine: relationship between effects on behaviour and cyclic nucleotide content in mouse brain.

Authors:  S W Gumulka; V Dinnendahl; D Bartmus; P S Schönhöfer; K Stock
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-05       Impact factor: 3.000

4.  Neurochemical effects of some ergot derivatives: a basis for their antiparkinson actions.

Authors:  R Markstein
Journal:  J Neural Transm       Date:  1981       Impact factor: 3.575

5.  Antiparkinsonian Agents : Clinically Significant Drug Interactions and Adverse Effects, and Their Management.

Authors:  A Dalvi; B Ford
Journal:  CNS Drugs       Date:  1998-04       Impact factor: 5.749

6.  Effects of clonidine and alpha-adrenoceptor antagonists on motor activity in DSP4-treated mice II: interactions with apomorphine.

Authors:  A Fredriksson; T Archer
Journal:  Neurotox Res       Date:  2000-04       Impact factor: 3.911

7.  Central catecholamine metabolism in vivo and the cognitive and motor deficits in Parkinson's disease.

Authors:  J J Mann; M Stanley; R D Kaplan; J Sweeney; A Neophytides
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-10       Impact factor: 10.154

8.  Clonidine in essential tremor: preliminary observations from an open trial.

Authors:  M R Caccia; A Mangoni
Journal:  J Neurol       Date:  1985       Impact factor: 4.849

Review 9.  Noradrenaline and 5-hydroxytryptamine modulation of brain dopamine function: implications for the treatment of Parkinson's disease.

Authors:  P Jenner; M Sheehy; C D Marsden
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.